Donor age is the most important predictor of long term graft function in donation after cardiac death simultaneous pancreas-kidney transplantation: A retrospective study.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
11 2019
Historique:
received: 18 11 2018
revised: 05 02 2019
accepted: 14 02 2019
pubmed: 16 3 2019
medline: 5 3 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Allografts donated after cardiac death (DCD) are the fastest growing organ source worldwide. Unfortunately, information is lacking on how to judge these organs' viability. Here, we analyzed the effects of donor characteristics, including age and BMI, on outcomes of DCD simultaneous-pancreas-kidney transplantation (SPK). We evaluated UNOS DCD-SPK transplants from 1988 to 2012. Effects of donor characteristics on graft and recipient survival were evaluated using Cox Regression and the Kaplan-Meier method, and compared to predictions from the pancreas and kidney donor risk indices (PDRI, KDRI). Compared to grafts≤40(n = 38), grafts>40(n = 189) had lower 1-year (73.4% ± 7.2% vs 88.2% ± 2.4%) and 10-year (50.3% ± 10% vs 66.3% ± 6.9%) pancreas survival, and twice the rate of kidney failure (HR2.1, 95%CI 1.15-3.83, p < 0.05) and pancreas failure (HR2.07, 95%CI 1.16-3.70, p < 0.05). BMI correlated with pancreas failure and recipient mortality. Donor age and BMI are significant predictors of DCD-SPK outcomes. Graft age appears to be as good a predictor of outcome as PDRI and KDRI.

Sections du résumé

BACKGROUND
Allografts donated after cardiac death (DCD) are the fastest growing organ source worldwide. Unfortunately, information is lacking on how to judge these organs' viability. Here, we analyzed the effects of donor characteristics, including age and BMI, on outcomes of DCD simultaneous-pancreas-kidney transplantation (SPK).
METHODS
We evaluated UNOS DCD-SPK transplants from 1988 to 2012. Effects of donor characteristics on graft and recipient survival were evaluated using Cox Regression and the Kaplan-Meier method, and compared to predictions from the pancreas and kidney donor risk indices (PDRI, KDRI).
RESULTS
Compared to grafts≤40(n = 38), grafts>40(n = 189) had lower 1-year (73.4% ± 7.2% vs 88.2% ± 2.4%) and 10-year (50.3% ± 10% vs 66.3% ± 6.9%) pancreas survival, and twice the rate of kidney failure (HR2.1, 95%CI 1.15-3.83, p < 0.05) and pancreas failure (HR2.07, 95%CI 1.16-3.70, p < 0.05). BMI correlated with pancreas failure and recipient mortality.
CONCLUSIONS
Donor age and BMI are significant predictors of DCD-SPK outcomes. Graft age appears to be as good a predictor of outcome as PDRI and KDRI.

Identifiants

pubmed: 30871789
pii: S0002-9610(18)31524-1
doi: 10.1016/j.amjsurg.2019.02.024
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

978-987

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Jingwen Chen (J)

Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

David M Mikhail (DM)

Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; Department of Surgery, Western University, London, ON, Canada.

Hemant Sharma (H)

Department of Surgery, Western University, London, ON, Canada.

Jeffrey Jevnikar (J)

Faculty of Engineering, Ryerson University, Toronto, ON, Canada.

Matthew Cooper (M)

Medstar Georgetown Transplant Institute, Washington, D.C, USA.

Patrick P Luke (PP)

Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; Department of Surgery, Western University, London, ON, Canada; Matthew Mailing Center for Translational Transplant Studies, Western University, London, ON, Canada.

Alp Sener (A)

Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; Department of Surgery, Western University, London, ON, Canada; Matthew Mailing Center for Translational Transplant Studies, Western University, London, ON, Canada; Department of Microbiology and Immunology, Western University, London, ON, Canada. Electronic address: alp.sener@lhsc.on.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH